The US Food and Drug Administration (FDA) has issued a warning letter to Amarillo Snuff over its smokeless nicotine product that uses corn husks instead of tobacco leaves
The US government is opposing a bill that would prevent the Food and Drug Administration (FDA) from enforcing a ban on menthol cigarettes it proposed last year
22nd Century will focus on streamlining operating costs and making the marketing and sales push for its VLN cigarette products more cost efficient to address issues that have forced it to revise full-year profit guidance
Altria reported a solid performance in the first half of 2023 despite lower net revenues, partially offset by higher revenue in the oral tobacco segment
Sales of HeatSticks could ironically end up benefitting from a US legal battle lost by their manufacturer Philip Morris and other leading tobacco companies
Lawyers for RJ Reynolds Tobacco Company call the US Food and Drug Administration’s defence of its graphic cigarette warnings “half-hearted” in a new legal brief
British American Tobacco (BAT) has reported a continued positive performance of its vapour and modern oral segment but said it needs to do more work on its heated tobacco products
Philip Morris International (PMI) reported strong momentum over the first half of the year, driven by Iqos growth and the good performance of Swedish Match, accelerating the company’s transition to a smokeless future
22nd Century Group has confirmed the launch of its VLN reduced nicotine cigarettes in California, where sales have begun in hundreds of convenience stores across the state
The US Food and Drug Administration Center for Tobacco Products has published milestones to expect as it continues to address issues brought up by the Reagan-Udall Foundation’s recent report
UK-based tobacco group Imperial Brands has acquired a range of nicotine pouch products from Canadian manufacturer TJP Labs for £65m, and said the move would facilitate its entry into the US modern oral nicotine market
The Reagan-Udall Foundation’s reports on the US Food and Drug Administration (FDA) provide “substantially different future policy implications” for the different FDA programmes investigated
US company 22nd Century will look to expand its international interests by launching trials in Switzerland and Japan as well as relaunching its low-nicotine conventional cigarette product in South Korea
US tobacco giant Altria is to pay $235m to settle at least 6,000 state and federal cases related to Juul, ending most of the suits it is still facing in relation to the e-cigarette company
Tobacco companies are not doing enough to transition to reduced risk products and are not phasing out conventional cigarettes quickly enough, according to the Foundation for a Smoke-Free World (FSFW)
US tobacco giant Altria closed the first quarter of 2023 with a slight fall in its net revenues compared with the same period last year, while it recorded an increase in its adjusted diluted earnings per share (EPS)
Philip Morris International will focus on heated tobacco and nicotine pouches as the alternatives that can help it meet its goal of becoming a majority smoke-free revenue company by 2025
A US House of Representatives committee has launched an investigation into the Food and Drug Administration (FDA)’s Center for Tobacco Products (CTP) for alleged failure to effectively regulate tobacco products
Expanding sales of next generation products into new markets has more than compensated Imperial Brands for the enforced loss of its Myblu e-cigarette from the US market
22nd Century Group, maker of the very low nicotine VLN brand cigarette, has announced a new three-year exclusive licence and distribution agreement with the US cannabis company Cookies
Altria will launch two new smoke-free products, a heated tobacco capsule called Swic and a new addition to its existing nicotine pouch brand, On! Plus, in a move to address a broader range of consumers and is actively considering international expansion
Altria is considering including cannabis as well as caffeine pouches in its offering of non-nicotine products as part of its growth strategy
As budget negotiations leave out the proposed ban on menthol cigarettes, tensions rise among lawmakers, public health advocates, and business organisations. Will the ban find its way back into legislation, or is this the end of the road?
Fears have been raised that new product standards proposed by the US Food and Drug Administration (FDA) may be costly to implement and overly burdensome for smaller companies
US-based 22nd Century believes it is set up for a bright future with further expansion of its VLN cigarette range into three new states and plans to be in 18 total by year’s end
Altria has swapped its 35% stake in Juul Labs for heated tobacco intellectual property rights, ending an investment which plummeted in value from $12.8bn to only $250m in just over four years
The significance Big Tobacco companies are placing on novel tobacco products is demonstrated by the continued international expansion many are undertaking
Altria is reported to be in advanced talks to buy e-cigarette company Njoy for around $2.75bn.No deal has been finalised, but an official announcement is possible by the end of the week
The US Food and Drug Administration (FDA) has announced its plans to address the recommendations put forward in a damning independent review of its Center for Tobacco Products (CTP)
The appointment of Matthew Farrelly as director of the Office of Science at the US Food and Drug Administration (FDA)’s Center for Tobacco Products (CTP) comes at a potentially critical time for tobacco alternatives
Page 2 of 9«12345...»Last »